Warberg Asset Management LLC Palisade Bio, Inc. Transaction History

Warberg Asset Management LLC

  • $12.6 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.11 - $83.85 $16,500 - $12.6 Million
150,000 New
150,000 $15,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email